A multimodal and integrated approach to interrogate human kidney biopsies with rigor and reproducibility: guidelines from the Kidney Precision Medicine Project
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Comprehensive and spatially mapped molecular atlases of organs at a cellular level are a critical resource to gain insights into pathogenic mechanisms and personalized therapies for diseases. The Kidney Precision Medicine Project (KPMP) is an endeavor to generate three-dimensional (3-D) molecular atlases of healthy and diseased kidney biopsies by using multiple state-of-the-art omics and imaging technologies across several institutions. Obtaining rigorous and reproducible results from disparate methods and at different sites to interrogate biomolecules at a single-cell level or in 3-D space is a significant challenge that can be a futile exercise if not well controlled. We describe a “follow the tissue” pipeline for generating a reliable and authentic single-cell/region 3-D molecular atlas of human adult kidney. Our approach emphasizes quality assurance, quality control, validation, and harmonization across different omics and imaging technologies from sample procurement, processing, storage, shipping to data generation, analysis, and sharing. We established benchmarks for quality control, rigor, reproducibility, and feasibility across multiple technologies through a pilot experiment using common source tissue that was processed and analyzed at different institutions and different technologies. A peer review system was established to critically review quality control measures and the reproducibility of data generated by each technology before their being approved to interrogate clinical biopsy specimens. The process established economizes the use of valuable biopsy tissue for multiomics and imaging analysis with stringent quality control to ensure rigor and reproducibility of results and serves as a model for precision medicine projects across laboratories, institutions and consortia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The FAIR Guiding Principles for scientific data management and stewardship
Wilkinson, M. D., Dumontier, M., Aalbersberg, I. J., Appleton, G., Axton, M., Baak, A., Blomberg, N., Boiten, J.-W., da Silva Santos, L. B., Bourne, P. E., et al. (2016) · Scientific Data · doi:10.1038/sdata.2016.18 · Cited by 18,423
A subcellular map of the human proteome
Thul, P. J., Åkesson, L., Wiking, M., Mahdessian, D., Geladaki, A., Ait Blal, H., Alm, T., Asplund, A., Björk, L., Breckels, L. M., et al. (2017) · Science · doi:10.1126/science.aal3321 · Cited by 2,813
The “All of Us” Research Program
The All of Us Research Program Investigators (2019) · New England Journal of Medicine · doi:10.1056/nejmsr1809937 · Cited by 2,440
Regev, A., Teichmann, S. A., Lander, E. S., Amit, I., Benoist, C., Birney, E., Bodenmiller, B., Campbell, P., Carninci, P., Clatworthy, M., et al. (2017) · eLife · doi:10.7554/elife.27041 · Cited by 2,232 · cited 2×
“Application of these technologies at the level of the genome, transcriptome, proteome, and metabolome have enabled identification of regulatory cascades and their mapping into tissue compartments at a single-cell resolution (12, 17, 18, 22, 23, 25, 27).”
BackgroundAn atlas of genetic influences on human blood metabolites
The Multiple Tissue Human Expression Resource (MuTHER) Consortium, Shin, S.-Y., Fauman, E. B., Petersen, A.-K., Krumsiek, J., Santos, R., Huang, J., Arnold, M., Erte, I., Forgetta, V., et al. (2014) · Nature Genetics · doi:10.1038/ng.2982 · Cited by 1,515
Reyfman, P. A., Walter, J. M., Joshi, N., Anekalla, K. R., McQuattie-Pimentel, A. C., Chiu, S., Fernandez, R., Akbarpour, M., Chen, C.-I., Ren, Z., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201712-2410oc · Cited by 1,203 · cited 1×
“Application of these technologies at the level of the genome, transcriptome, proteome, and metabolome have enabled identification of regulatory cascades and their mapping into tissue compartments at a single-cell resolution (12, 17, 18, 22, 23, 25, 27).”
BackgroundDistribution of miRNA expression across human tissues
Ludwig, N., Leidinger, P., Becker, K., Backes, C., Fehlmann, T., Pallasch, C., Rheinheimer, S., Meder, B., Stähler, C., Meese, E., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw116 · Cited by 968
Single-cell genomics identifies cell type–specific molecular changes in autism
Velmeshev, D., Schirmer, L., Jung, D., Haeussler, M., Perez, Y., Mayer, S., Bhaduri, A., Goyal, N., Rowitch, D. H., & Kriegstein, A. R. (2019) · Science · doi:10.1126/science.aav8130 · Cited by 927
The human body at cellular resolution: the NIH Human Biomolecular Atlas Program
HuBMAP Consortium, Writing Group, Snyder, M. P., Lin, S., Posgai, A., Atkinson, M., Regev, A., Rood, J., Rozenblatt-Rosen, O., Gaffney, L., et al. (2019) · Nature · doi:10.1038/s41586-019-1629-x · Cited by 595 · cited 1×
“The framework established serves as a paradigm for similar atlas efforts and precision medicine projects of other organs systems and diseases and a guide to investigators to generate high quality and reproducible data from limited tissue (1, 9, 10, 17).”
Self-citationMetabolomics reveals signature of mitochondrial dysfunction in diabetic kidney disease
Sharma, K., Karl, B., Mathew, A. V., Gangoiti, J. A., Wassel, C. L., Saito, R., Pu, M., Sharma, S., You, Y.-H., Wang, L., et al. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013020126 · Cited by 571 · cited 1×
“Investigators have begun to apply single-cell omics and high-resolution imaging technologies to healthy or diseased kidney biopsy tissue to provide important information on the cell type composition and spatial relationships in diseases like lupus nephritis, diabetes, and in healthy tissue (21, 24).”
BackgroundSelf-citation
Cited by
An atlas of healthy and injured cell states and niches in the human kidney
Lake, B. B., Menon, R., Winfree, S., Hu, Q., Melo Ferreira, R., Kalhor, K., Barwinska, D., Otto, E. A., Ferkowicz, M., Diep, D., et al. (2023) · Nature · doi:10.1038/s41586-023-05769-3 · Cited by 743
Self-citationSARS-CoV-2 infects the human kidney and drives fibrosis in kidney organoids
Jansen, J., Reimer, K. C., Nagai, J. S., Varghese, F. S., Overheul, G. J., de Beer, M., Roverts, R., Daviran, D., Fermin, L. A. S., Willemsen, B., et al. (2022) · Cell Stem Cell · doi:10.1016/j.stem.2021.12.010 · Cited by 259
Self-citationRationale and design of the Kidney Precision Medicine Project
de Boer, I. H., Alpers, C. E., Azeloglu, E. U., Balis, U. G. J., Barasch, J. M., Barisoni, L., Blank, K. N., Bomback, A. S., Brown, K., Dagher, P. C., et al. (2021) · Kidney International · doi:10.1016/j.kint.2020.08.039 · Cited by 187
Self-citationData Integration Challenges for Machine Learning in Precision Medicine
Martínez-García, M., & Hernández-Lemus, E. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2021.784455 · Cited by 185
Waljee, A. K., Weinheimer-Haus, E. M., Abubakar, A., Ngugi, A. K., Siwo, G. H., Kwakye, G., Singal, A. G., Rao, A., Saini, S. D., Read, A. J., et al. (2022) · Gut · doi:10.1136/gutjnl-2022-327211 · Cited by 68
Metadata
- Authors
- El-Achkar, T. M., Eadon, M. T., Menon, R., Lake, B. B., Sigdel, T. K., Alexandrov, T., Parikh, S., Zhang, G., Dobi, D., Dunn, K. W., Otto, E. A., Anderton, C. R., Carson, J. M., Luo, J., Park, C., Hamidi, H., Zhou, J., Hoover, P., Schroeder, A., Joanes, M., Azeloglu, E. U., Sealfon, R., Winfree, S., Steck, B., He, Y., D’Agati, V., Iyengar, R., Troyanskaya, O. G., Barisoni, L., Gaut, J., Zhang, K., Laszik, Z., Rovin, B. H., Dagher, P. C., Sharma, K., Sarwal, M. M., Hodgin, J. B., Alpers, C. E., Kretzler, M., & Jain, S.
- Venue
- Physiological Genomics
- Publisher
- American Physiological Society
- Published
- 2021-01-01
- Volume
- 53
- Issue
- 1
- Pages
- 1-11
- ISSN
- 1094-8341 (ISSN-L)
- 1531-2267
- OpenAlex
- W3100860590
- Cited by
- 74
- References
- 11
- FWCI
- 3.32
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.